What is the current valuation of the France biobanking market in 2024?

The overall market valuation was $3392.69 Million in 2024. Read More

What is the projected market valuation for the France biobanking market by 2035?

The projected valuation for 2035 is $5296.93 Million. Read More

What is the expected CAGR for the France biobanking market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 4.13%. Read More

What are the main sample types in the France biobanking market and their valuations?

Sample types include Blood Products, Tissues, Cells, Nucleic Acids, and Microbiome Samples, each valued between $678.54 Million and $1050.0 Million. Read More

How does the application segment of the France biobanking market perform?

The application segment includes Research and Development, Clinical Trials, Personalized Medicine, and Regenerative Medicine, with valuations ranging from $678.54 Million to $1616.93 Million. Read More

What are the end-use categories in the France biobanking market?

End-use categories include Academic Research Institutions, Biotechnology Companies, Pharmaceutical Companies, and Government Organizations, with valuations from $663.15 Million to $1800.0 Million. Read More

What storage types are utilized in the France biobanking market?

Storage types include Vapor Phase Storage, Liquid Phase Storage, and Cryopreservation Storage, with valuations between $600.0 Million and $2596.93 Million. Read More

What is the significance of the pharmaceutical companies in the France biobanking market?

Pharmaceutical Companies represent a substantial segment, with valuations projected between $1200.0 Million and $1800.0 Million. Read More

How does the biobanking market in France compare to other regions?

While specific regional comparisons are not provided, the growth trajectory and key players suggest a robust and competitive landscape in France. Read More

France Biobanking Market

Q: Which companies are considered key players in the France biobanking market?

Key players include Thermo Fisher Scientific, Qiagen, Illumina, Merck KGaA, STEMCELL Technologies, BioLife Sciences, ReproCELL, and Biobanking Solutions. Read More

ID: MRFR/MED/52635-HCR

200 Pages

Rahul Gotadki

Last Updated: April 24, 2026

France Biobanking Market Research Report: Size, Share, Trend Analysis By Sample Type (Blood Products, Tissues, Cells, Nucleic Acids, Microbiome Samples), By Applications (Research and Development, Clinical Trials, Personalized Medicine, Regenerative Medicine), By End Use (Academic Research Institutions, Biotechnology Companies, Pharmaceutical Companies, Government Organizations) and By Storage Type (Vapor Phase Storage, Liquid Phase Storage, Cryopreservation Storage) - Growth Outlook & Industry Forecast 2025 To 2035

France Biobanking Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)4.13%

2024 Market Size$ 3,392.69 Million

2025 Market Size$ 3,532.8 Million

2035 Market Size$ 5,296.93 Million

Key Players

Thermo Fisher Scientific

Qiagen

Illumina

Merck KGaA

STEMCELL Technologies

BioLife Sciences

Trends

Technological Advancements
Regulatory Support
Focus on Precision Medicine

Opportunities

Supportive Regulatory Framework
Advancements in Biobanking Technologies
Rising Demand for Personalized Healthcare

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Sample Type (USD Million)
  1. 4.1.1 Blood Products
  2. 4.1.2 Tissues
  3. 4.1.3 Cells
  4. 4.1.4 Nucleic Acids
  5. 4.1.5 Microbiome Samples
2. 4.2 Medical Device, BY Application (USD Million)
  1. 4.2.1 Research and Development
  2. 4.2.2 Clinical Trials
  3. 4.2.3 Personalized Medicine
  4. 4.2.4 Regenerative Medicine
3. 4.3 Medical Device, BY End-use (USD Million)
  1. 4.3.1 Academic Research Institutions
  2. 4.3.2 Biotechnology Companies
  3. 4.3.3 Pharmaceutical Companies
  4. 4.3.4 Government Organizations
4. 4.4 Medical Device, BY Storage Type (USD Million)
  1. 4.4.1 Vapor Phase Storage
  2. 4.4.2 Liquid Phase Storage
  3. 4.4.3 Cryopreservation Storage
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Thermo Fisher Scientific (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Qiagen (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Illumina (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Merck KGaA (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 STEMCELL Technologies (CA)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 BioLife Sciences (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 ReproCELL (JP)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Biobanking Solutions (NL)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 FRANCE MARKET ANALYSIS BY SAMPLE TYPE
3. 6.3 FRANCE MARKET ANALYSIS BY APPLICATION
4. 6.4 FRANCE MARKET ANALYSIS BY END-USE
5. 6.5 FRANCE MARKET ANALYSIS BY STORAGE TYPE
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY SAMPLE TYPE, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY SAMPLE TYPE, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY END-USE, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY END-USE, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY STORAGE TYPE, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY STORAGE TYPE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SAMPLE TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END-USE, 2025-2035 (USD Million)
  4. 7.2.4 BY STORAGE TYPE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

France Biobanking Market Segmentation

France Biobanking Market By Sample Type (USD Million, 2025-2035)

Blood Products
Tissues
Cells
Nucleic Acids
Microbiome Samples

France Biobanking Market By Application (USD Million, 2025-2035)

Research and Development
Clinical Trials
Personalized Medicine
Regenerative Medicine

France Biobanking Market By End-use (USD Million, 2025-2035)

Academic Research Institutions
Biotechnology Companies
France Biobanking Market Companies
Government Organizations

France Biobanking Market By Storage Type (USD Million, 2025-2035)

Vapor Phase Storage
Liquid Phase Storage
Cryopreservation Storage

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”